SEC Form 4 · accession 0001179110-17-011574
OMNICELL, INC. · OMCL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robin Gene Seim
Officer — EVP, Global A & M Adherence
Period of report
Aug 15, 2017
Accepted (ET)
Aug 16, 2017 · 6:53 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000926326
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF3,F1 | Aug 15, 2017 | S | 2,248 | $50.8992 | D | 55,896 | D | |
| Common StockF3,F2 | Aug 15, 2017 | S | 12,861 | $50.8562 | D | 43,035 | D | |
| Common Stock | Aug 15, 2017 | M | 12,861 | $0.00 | A | 55,896 | D | |
| Common Stock | holding | — | — | — | 58,144 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non qualified option (right to buy)F3 | $25.08 | Aug 15, 2017 | M | 8,850 | A | Feb 4, 2015 | Feb 4, 2024 | Common Stock | 8,850 | 8,850 | D |
| Non qualified Option (right to buy)F3 | $17.29 | Aug 15, 2017 | M | 4,011 | A | Feb 5, 2014 | Feb 5, 2023 | Common Stock | 4,011 | 4,011 | D |
Explanation of responses
- F1The price reported in Column 4 is the average price of $50.8992. The shares sold between $50.45 to $51.30. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F2The price reported in Column 4 is the average price of $50.85620. The shares sold between $50.50 to $51.30. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan.